As cancer rates rise, many patients seek diagnostic services abroad, leading to delays and increased costs. The region lacks adequate Molecular Imaging and Nuclear Medicine services, highlighting a critical need for local solutions.
Xenopia Group provides advanced Radiopharmaceuticals and contract development services for hospitals and research institutions. Our mission is to ensure that every patient in the region has local access to essential diagnostic and therapeutic services in the fight against cancer.
So far, we have partnered with seven healthcare institutions in East Africa, and we aim to expand our services to 20 healthcare facilities by 2026, each serving at least 100 patients annually.
Our experienced team, strategic partnerships, significant market potential, and commitment to impactful change make Xenopia Group a transformative investment opportunity, improving patient outcomes and reducing the burden of overseas travel. Invest in us for a healthier future!
| Sectors | Healthcare, Medical equipment and supplies, Pharmaceuticals |
| Location | Nairobi, Kenya |
| Stage | Sign in to view details |
| Markets | Sign in to view details |
| Customer model | Sign in to view details |
| Revenue | Sign in to view details |
| Contact | Sign in to view details |
| Social media |